Diabetes Diagnostics Market Forecast, Trend, Analysis & Competition Tracking - Global Market Insights 2020 to 2030

Published on : Dec-2020 | List of Tables : 34 | List of Figures : 141 | No. of Pages : 170 | Report Code : FACT5446MR |

Diabetes Diagnostics Market: About the Report

Demand for diabetes diagnostics is expected to rise in response to surging hospitalizations amid the COVID-19 surge. Studies identifying diabetics at higher risk of getting critically ill if infected by the virus are fuelling demand for various related products, including diabetes test strips. Fact.MR, in its recent report, has projected that demand from hospitals will continue increasing through the forecast period from 2020 and 2030. Government funding towards building hospitals to make healthcare better accessible in rural areas will aid overall expansion of the market. North America, Asia Pacific, and Europe will be attractive regions for players in the global diabetes diagnostics market through 2030.

Diabetes Diagnostics Market Overview

Driven by the increasing incidence of diabetes, the global diabetes diagnostics market is exhibiting notable growth. According to the World Health Organization (WHO), 422 million people around the world have diabetes. Prevalence of diabetes is higher in low- and middle-income countries, as per the WHO’s findings. Besides this, diabetes also is identified as a principal reason behind rising kidney failure, blindness, heart attacks, stroke, and lower limb amputation cases.

According to Fact.MR, the rising incidence of diabetes is expected to fuel the demand for better-performance and smarter diabetes diagnostics to increase significantly between 2020 and 2030.As per the WHO, globally, over 1.9 billion adults aged 18 years and older were overweight in 2016. Of these, more than 650 million adults were obese. Obesity is known to be one of the key conditions that can lead to diabetes. Higher prevalence of obesity will therefore stoke growth opportunities for the diabetes diagnostics market.

Advent of Nanotechnology Propelling Growth

Nanotechnology is at the forefront of technologies that are forecast to offer a reliable methodology in the early and precise diagnosis and treatment of diabetes. Several benefits of nanotechnology, such as drug release control and target specification, are driving experts to develop advanced glucose detection and insulin delivery methods using nanotechnology. Such advancements are likely to boost the growth of the global diabetes diagnostics market.

Nanotechnology gives access to advanced sensing technologies to provide timely and more accurate information on diabetes. A pair of researchers from the Oregon State University College of Engineering developed means to print transistor-based glucose sensors onto a catheter attached to a wearable pump. This technology allowed diabetics to program the pump to deliver glucagon and insulin at precise doses and time.

A slew of studies similar the one mentioned are undertaken in the last few years to study the use of nanotechnology in diabetes. A common aim of these researches is to offer timely and accurate diagnosis. Spurred by this, the diabetes diagnostics market will exhibit significant growth over the coming years.

Lack of Awareness Limiting Market Growth

The diabetes diagnostics market is hampered by lack of awareness about diabetes and its effects. In 2015, according to UK National Health Service (NHS), nearly 3.9 million people were diagnosed with diabetes, and more than 590,000 people were unaware and undiagnosed. This might restrict the overall growth opportunities for the market.

Regional Outlook of Diabetes Diagnostics Market

North America is one of the most attractive markets for diabetes diagnostics. Rising healthcare expenditure is one of the biggest factors accountable for the region's exceptional growth. For instance, in 2019, Canada's per-capita spending on health ranked 11th amongst health-care systems in the Organization for Economic Co-operation and Development (OECD). Besides this, increasing Food and Drug Administration (FDA) approvals to some of the leading market players in countries such as the U.S. and Canada are also boosting the growth of the diabetes diagnostics market in North America. For instance, in February 2020, Abbott obtained FDA permission for the use of FreeStyle Libre 14-day Flash glucose monitoring systems in hospitals and clinics.

Asia Pacific has also emerged as a lucrative market for diabetes diagnostics. Rising diabetic population in economies such as China and India is driving growth in the region. Increasing government funds, initiatives, and education on health awareness are further augmenting the demand for diabetes diagnostics in the region. For instance, the New Rural Co-operative Medical Care System (NRCMCS) is intended at making the healthcare system more affordable for rural people in China. It covered nearly 98% of rural residents in 2018. Such initiatives towards the developing healthcare sector in underdeveloped areas of the developing countries are promoting diabetes diagnostics market growth.

Besides North America and Asia Pacific, Europe accounts for a sizeable share of the global diabetes diagnostics market. Growth witnessed in the region is primarily due to the growing diabetes cases in the region. According to the WHO, deaths caused due to diabetes are expected to double by 2030 as compared to 2005. Furthermore, increasing projects towards the expansion of healthcare are likely to augment market growth. For instance, the NOVEL project is intended to transform healthcare in Europe. The European Union's Horizon 2020 funded the NOBEL Coordination and Support Action. Such projects are expected to fuel demand for smarter diabetes diagnostics during the forecast period.

diabetes diagnostics market regional analysis

For more valuable information on regional market dynamics for diabetes diagnostics, request a report sample

Diabetes Diagnostics Market Insights by Product

According to Fact.MR, the test strips segment is forecast to witness surging demand during the assessment period, in terms of product in the diabetes diagnostics market space. Test strips manufacturers are increasingly launching low-cost products. Besides this, rising investment is propelling growth within the segment. For instance, In June 2018, LaunchByte, an investment company, invested in StripSupply, a Boston-based blood glucose testing Product Company. This investment helped StipSupply in stimulating the development of low-cost test strips, and their production and sales.

Besides this, the continuous glucose monitors (CGM) segment is also expected to showcase noteworthy growth owing to the development of smarter CGMs. Moreover, the growing interest of players in collaborations is also supporting the growth of this segment. For instance, Medtronic Plc partnered with Eris Lifesciences to produce a smart continuous glucose monitoring system in January 2019.

Diabetes Diagnostics Market Insights by End User

Based on end user, hospitals are likely to account for a sizeable share of the market in terms of market value. Growing number of hospitals and the rising number of facilities across the world are key factors behind the growth of this segment.

Besides, rising government expenditure on healthcare is augmenting the demand for diabetes diagnostics in hospitals and among other end users. For instance, according to National Health Expenditure Accounts (NHEA), health care spending in the U.S. grew 4.6 percent in 2019 and reached $3.8 trillion or $11,582 per person. Such rising spending coupled with increasing healthcare awareness is driving more patients to diabetes diagnosis, which is benefitting the market.

Diabetes Diagnostics Market: Competitive Landscape

The market for diabetes diagnostics is getting extremely competitive owing to the rising cases of around the world and increasing willingness among patients to spend on advanced healthcare. With rising number of new entrants in the diabetes diagnostics market, established players are focusing on technological advancement and frequent new product launches to maintain their positions.

For instance, in June 2018, Senseonics gained FDA's permission for its Implantable Eversense Continuous Glucose Monitoring (CGM) system in the US. This long-term system is one of the major discoveries of diabetes devices. The device monitors blood glucose levels for 90 days without the use of lancets and is gaining immense popularity among patients.

Besides this, leading players are focusing on collaborations to expand their regional footprint. For instance, in January 2020, LifeScan, a US-based company entered into collaboration with DKSH, a company specialized in market expansion services, especially in Asia Pacific. With this partnership, DKSH will provide supervisory assistance and distribution and logistics for the sales of LifeScan products in other countries such as Philippines, Vietnam, Malaysia, Indonesia, Thailand, Hong Kong, and Taiwan.

Some of the leading players operating in the diabetes diagnostics market include Medtronic plc, Abbott Laboratories, F.Hoffmann-La-Ltd., Bayer AG, Lifescan, Inc., B Braun Melsungen AG, Lifescan, Inc., Dexcom Inc., Insulet Corporation, Ypsomed Holdings, Companion Medical, Sanofi, Valeritas Holding Inc., Novo Nordisk, and Arkray, Inc., among others.

The Analyst's Viewpoint

"Companies operating in the market are seeking out opportunities to expand footprint across East and South Asia. As a result they are focusing on launching affordable diabetes supplies to gain competitive edge. Besides this, rising incidence of diabetes will continue supporting the expansion of the market in the region."

COVID-19 Impact on Diabetes Diagnostics Market

Like in other markets, negative impacts of the COVID-19 pandemic are posing numerous challenges to the growth of the diabetes diagnostics market also. Social distancing norms and transportation restrictions imposed by governments have led to a shortage of workers and raw materials. This consequently resulted in disrupting manufacturing activities during the initial phases of the pandemic.

Several international organizations are issuing health advisories to contain the spread of COVID-19. Awareness initiatives undertaken by these organizations are expected to accelerate the market’s growth amid the pandemic crisis. For instance, the International Diabetes Federation has stated that diabetic people are more vulnerable to becoming critically ill if infected by the COVID-19 virus. Hence, growing health awareness and the relation of COVID-19 with diabetes is projected to support the growth of the market.

Diabetes Diagnostics Market- Scope of the Report

A recent study by Fact.MR on the diabetes diagnostics market offers a 10-year forecast for 2020 and 2030. The study analyzes crucial trends that are currently determining the growth of the diabetes diagnostics market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders. The study also provides the dynamics that are responsible for influencing the future status of the diabetes diagnostics market over the forecast period.

A detailed assessment of diabetes diagnostics value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the diabetes diagnostics market along with their product portfolios enhances the reliability of this comprehensive research study.

Diabetes Diagnostics Market: Report Summary

The study offers a comprehensive analysis on diverse features, including demand, product developments, revenue generation, and sales in the diabetes diagnostics market across the globe.

A comprehensive estimate on the diabetes diagnostics market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of diabetes diagnostics during the forecast period. Price point comparison by region with global average price is also considered in the study.

Diabetes Diagnostics Market: Segmentation

Fact.MR has studied the diabetes diagnostics market with detailed segmentation on the basis of by product type, end user, and key region.

Product

  • Biochips
  • Test Strips
  • Lancets
  • Analog Glucose Monitors
  • Continuous Glucose Monitors
End User
  • Hospitals
  • Clinics
  • Diagnostics Centers
  • Homecare Settings
Region
  • North America
  • Europe
  • Latin America
  • Middle East & Africa
  • Oceania
  • East Asia
  • South Asia

Key Questions Answered in Fact.MR’s Diabetes Diagnostics Market Report

  • Which regions will continue to remain the most profitable regional markets for diabetes diagnostics market players?
  • Which factors will induce a change in the demand for diabetes diagnostics during the assessment period?
  • How will changing trends impact the diabetes diagnostics market?
  • How can market players capture the low-hanging opportunities in the diabetes diagnostics market in developed regions?
  • Which companies are leading the diabetes diagnostics market?
  • What are the winning strategies of stakeholders in the diabetes diagnostics market to upscale their position in this landscape?

Diabetes Diagnostics Market: Research Methodology

In Fact.MR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the diabetes diagnostics market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the drawn conclusions.

Secondary resources referred to by analysts during the preparation of diabetes diagnostics market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of the diabetes diagnostics market report as a primary resource.

Diabetes Diagnostics Market: Analysis on Market Size Evaluation

The Diabetes diagnostics market has been analyzed for each market segment in terms of value (US$ Mn).

Market estimates at global and regional levels for diabetes diagnostics are available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent diabetes diagnostics market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global diabetes diagnostics market.

Diabetes Diagnostics Market: Inspected Assessment on Regional Segments

Key sections have been elaborated in the diabetes diagnostics market report, which have helped deliver projections on regional markets. These chapters include regional macros (political economic and business environment outlook), which are expected to have a momentous influence on the growth of the diabetes diagnostics market during the forecast period.

Country-specific valuation on demand for diabetes diagnostics has been offered for each regional market, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value and volume for emerging countries has also been included in the report.

Diabetes Diagnostics Market: In-depth Analysis on Competitive Landscape

The report sheds light on the leading manufacturers of marine adhesives, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of diabetes diagnostics has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolio and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status and predicting the competition level in diabetes diagnostics market. Prominent companies operating in the global diabetes diagnostics include Medtronic plc, Abbott Laboratories, F.Hoffmann-La-Ltd., Bayer AG, Lifescan, Inc., B Braun Melsungen AG, Lifescan, Inc., Dexcom Inc., Insulet Corporation, Ypsomed Holdings, Companion Medical, Sanofi, Valeritas Holding Inc., Novo Nordisk, and Arkray, Inc., among others.

Table of Contents

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Market Context

    4.1. Epidemiology of diabetes

    4.2. Product Adoption / Usage Analysis

    4.3. Regulatory Scenario 

    4.4. Key Promotional Strategies by Manufacturer

    4.5. Reimbursement Scenario

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Expenditure Outlook

        5.1.3. Income Per Capita Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Growth History of Top Manufacturers

        5.2.2. Rising prevalence of diabetes among population

        5.2.3. Adoption of early screening

        5.2.4. Technology advancement to aid Diabetes

        5.2.5. Rising awareness about diabetes management

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID19 Crisis Analysis

    6.1. Current COVID19 Statistics and Probable Future Impact

    6.2. Current GDP Projection and Probable Impact

    6.3. Current Economic Projection as compared to 2008 financial analysis

    6.4. COVID19 and Impact Analysis

        6.4.1. Revenue By Product

        6.4.2. Revenue By End User

        6.4.3. Revenue By Country

    6.5. 2020 Market Scenario

    6.6. Quarter by Quarter Forecast

    6.7. Projected recovery Quarter

    6.8. Recovery Scenario – Short term, Midterm and Long Term Impact

7. Global Diabetes Diagnostics Market Volume (‘000’ Units) Analysis 2015-2019 and Forecast, 2020-2030

    7.1. Historical Market Volume (‘000’ Units) Analysis, 2015-2019

    7.2. Current and Future Market Volume (‘000’ Units) Projections, 2020-2030

        7.2.1. Y-o-Y Growth Trend Analysis

8. Global Diabetes Diagnostics Market - Pricing Analysis

    8.1. Regional Pricing Analysis By Product

    8.2. Pricing Break-up

        8.2.1. Manufacturer Level Pricing

        8.2.2. Distributor Level Pricing

    8.3. Global Average Pricing Analysis Benchmark

9. Global Diabetes Diagnostics Market Demand Value or Size (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

    9.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

    9.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Global Diabetes Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, By Product

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) and Volume (‘000’ Units) Analysis By Product, 2015 - 2019

    10.3. Current and Future Market Size (US$ Mn) and Volume (‘000’ Units) Analysis and Forecast By Product, 2020 - 2030

        10.3.1. Test Strips

        10.3.2. Lancets

        10.3.3. Analog Glucose Monitors

        10.3.4. Continuous Glucose Monitors

    10.4. Market Attractiveness Analysis By Product

11. Global Diabetes Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, By End User

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) and Volume Analysis By End User, 2015 - 2019

    11.3. Current and Future Market Size (US$ Mn) and Volume (‘000’ Units) Analysis and Forecast By End User, 2020 – 2030

        11.3.1. Hospitals

        11.3.2. Clinics

        11.3.3. Diagnostic Centers

        11.3.4. Homecare settings

    11.4. Market Attractiveness Analysis By End User

12. Global Diabetes Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, by Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Region, 2015 - 2019

    12.3. Current and Future Market Size (US$ Mn) and Volume (‘000’ Units) Analysis and Forecast By Region, 2020 - 2030

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. East Asia

        12.3.5. South Asia

        12.3.6. Oceania

        12.3.7. Middle East and Africa (MEA)

    12.4. Market Attractiveness Analysis By Region

13. North America Diabetes Diagnostics Market  Analysis 2015-2019 and Forecast 2020-2030

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2019

    13.3. Current and Future Market Size (US$ Mn) and Volume (‘000’ Units) Analysis By Market Taxonomy, 2020-2030

        13.3.1.  By Country

            13.3.1.1. U.S.

            13.3.1.2. Canada

        13.3.2. By Product

        13.3.3. By End User

    13.4. Market Attractiveness Analysis

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. Latin America Diabetes Diagnostics Market  Analysis 2015-2019 and Forecast 2020-2030

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2019

    14.3. Current and Future Market Size (US$ Mn) and Volume (‘000’ Units) Analysis By Market Taxonomy, 2020-2030

        14.3.1.  By Country

            14.3.1.1. Brazil

            14.3.1.2. Mexico

            14.3.1.3. Argentina

            14.3.1.4. Rest of Latin America

        14.3.2. By Product

        14.3.3. By End User

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. Europe Diabetes Diagnostics Market  Analysis 2015-2019 and Forecast 2020-2030

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2019

    15.3. Current and Future Market Size (US$ Mn) and Volume (‘000’ Units) Analysis By Market Taxonomy, 2020-2030

        15.3.1. By Country

            15.3.1.1. Germany

            15.3.1.2. Italy

            15.3.1.3. France

            15.3.1.4. U.K.

            15.3.1.5. Spain

            15.3.1.6. BENELUX

            15.3.1.7. Russia

            15.3.1.8. Rest of Europe

        15.3.2. By Product

        15.3.3. By End User

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. South Asia Diabetes Diagnostics Market  Analysis 2015-2019 and Forecast 2020-2030

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2019

    16.3. Current and Future Market Size (US$ Mn) and Volume (‘000’ Units) Analysis By Market Taxonomy, 2020-2030

        16.3.1.  By Country

            16.3.1.1. India

            16.3.1.2. Thailand

            16.3.1.3. Indonesia

            16.3.1.4. Malaysia

            16.3.1.5. Rest of South Asia

        16.3.2. By Product

        16.3.3. By End User

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. East Asia Diabetes Diagnostics Market  Analysis 2015-2019 and Forecast 2020-2030

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2019

    17.3. Current and Future Market Size (US$ Mn) and Volume (‘000’ Units) Analysis By Market Taxonomy, 2020-2030

        17.3.1.  By Country

            17.3.1.1. China

            17.3.1.2. Japan

            17.3.1.3. South Korea

        17.3.2. By Product

        17.3.3. By End User

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. Oceania Diabetes Diagnostics Market  Analysis 2015-2019 and Forecast 2020-2030

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015 - 2019

    18.3. Current and Future Market Size (US$ Mn) and Volume (‘000’ Units) Analysis By Market Taxonomy, 2020-2030

        18.3.1.  By Country

            18.3.1.1. Australia

            18.3.1.2. New Zealand

        18.3.2. By Product

        18.3.3. By End User

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. Middle East and Africa Diabetes Diagnostics Market  Analysis 2015-2019 and Forecast 2020-2030

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) Trend Analysis By Market   Taxonomy, 2015 - 2019

    19.3. Current and Future Market Size (US$ Mn) and Volume (‘000’ Units) Analysis By Market Taxonomy, 2020-2030

        19.3.1.  By Country

            19.3.1.1. GCC Countries

            19.3.1.2. Turkey

            19.3.1.3. South Africa

            19.3.1.4. Rest of Middle East and Africa

        19.3.2. By Product

        19.3.3. By End User

    19.4. Market Attractiveness Analysis

    19.5. Key Market Participants - Intensity Mapping

    19.6. Drivers and Restraints - Impact Analysis

20. Emerging & Key Countries Diabetes Diagnostics Market  Analysis 2015-2019 and Forecast 2020-2030

    20.1. Introduction

        20.1.1. Market Value Proportion Analysis, By Key Countries

        20.1.2. Global Vs. Country Growth Comparison

    20.2. U. S.  Diabetes Diagnostics Market Analysis

        20.2.1. By Product

        20.2.2. By End User

    20.3. Canada Diabetes Diagnostics Market Analysis

        20.3.1. By Product

        20.3.2. By End User

    20.4. Mexico Diabetes Diagnostics Market Analysis

        20.4.1. By Product

        20.4.2. By End User

    20.5. Brazil Diabetes Diagnostics Market Analysis

        20.5.1. By Product

        20.5.2. By End User

    20.6. Germany Diabetes Diagnostics Market Analysis

        20.6.1. By Product

        20.6.2. By End User

    20.7. U. K. Diabetes Diagnostics Market Analysis

        20.7.1. By Product

        20.7.2. By End User

    20.8. France Diabetes Diagnostics Market Analysis

        20.8.1. By Product

        20.8.2. By End User

    20.9. Italy Diabetes Diagnostics Market Analysis

        20.9.1. By Product

        20.9.2. By End User

    20.10. Spain Diabetes Diagnostics Market Analysis

        20.10.1. By Product

        20.10.2. By End User

    20.11. Russia Diabetes Diagnostics Market Analysis

        20.11.1. By Product

        20.11.2. By End User

    20.12. China Diabetes Diagnostics Market Analysis

        20.12.1. By Product

        20.12.2. By End User

    20.13. Japan Diabetes Diagnostics Market Analysis

        20.13.1. By Product

        20.13.2. By End User

    20.14. South Korea Diabetes Diagnostics Market Analysis

        20.14.1. By Product

        20.14.2. By End User

    20.15. India Diabetes Diagnostics Market  Analysis

        20.15.1. By Product

        20.15.2. By End User

    20.16. Thailand Diabetes Diagnostics Market  Analysis

        20.16.1. By Product

        20.16.2. By End User

    20.17. Malaysia Diabetes Diagnostics Market  Analysis

        20.17.1. By Product

        20.17.2. By End User

    20.18. Indonesia Diabetes Diagnostics Market  Analysis

        20.18.1. By Product

        20.18.2. By End User

    20.19. Australia Diabetes Diagnostics Market Analysis

        20.19.1. By Product

        20.19.2. By End User

    20.20. New Zealand Diabetes Diagnostics Market Analysis

        20.20.1. By Product

        20.20.2. By End User

    20.21. GCC Countries Diabetes Diagnostics Market   Analysis

        20.21.1. By Product

        20.21.2. By End User

    20.22. Turkey Countries Diabetes Diagnostics Market  Analysis

        20.22.1. By Product

        20.22.2. By End User

    20.23. South Africa Diabetes Diagnostics Market  Analysis

        20.23.1. By Product

        20.23.2. By End User

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies

    21.2. Market Concentration

    21.3. Market Share Analysis of Top Players

    21.4. Market Presence Analysis

        21.4.1. By Regional footprint of Players

        21.4.2. Product foot print by Players

        21.4.3. Channel Foot Print by Players

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Competition Deep Dive

        22.3.1. Abbott Laboratories

            22.3.1.1. Overview

            22.3.1.2. Product Portfolio

            22.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.1.4. Sales Footprint

            22.3.1.5. Strategy Overview

                22.3.1.5.1. Marketing Strategy

                22.3.1.5.2. Product Strategy

                22.3.1.5.3. Channel Strategy

        22.3.2. Becton Dickinson & Company

            22.3.2.1. Overview

            22.3.2.2. Product Portfolio

            22.3.2.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.2.4. Sales Footprint

            22.3.2.5. Strategy Overview

                22.3.2.5.1. Marketing Strategy

                22.3.2.5.2. Product Strategy

                22.3.2.5.3. Channel Strategy

        22.3.3. F. Hoffmann-La Roche AG

            22.3.3.1. Overview

            22.3.3.2. Product Portfolio

            22.3.3.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.3.4. Sales Footprint

            22.3.3.5. Strategy Overview

                22.3.3.5.1. Marketing Strategy

                22.3.3.5.2. Product Strategy

                22.3.3.5.3. Channel Strategy

        22.3.4. Medtronic PLC

            22.3.4.1. Overview

            22.3.4.2. Product Portfolio

            22.3.4.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.4.4. Sales Footprint

            22.3.4.5. Strategy Overview

                22.3.4.5.1. Marketing Strategy

                22.3.4.5.2. Product Strategy

                22.3.4.5.3. Channel Strategy

        22.3.5. B Braun Melsungen AG

            22.3.5.1. Overview

            22.3.5.2. Product Portfolio

            22.3.5.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.5.4. Sales Footprint

            22.3.5.5. Strategy Overview

                22.3.5.5.1. Marketing Strategy

                22.3.5.5.2. Product Strategy

                22.3.5.5.3. Channel Strategy

        22.3.6. DexCom Inc.

            22.3.6.1. Overview

            22.3.6.2. Product Portfolio

            22.3.6.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.6.4. Sales Footprint

            22.3.6.5. Strategy Overview

                22.3.6.5.1. Marketing Strategy

                22.3.6.5.2. Product Strategy

                22.3.6.5.3. Channel Strategy

        22.3.7. Bayer Corporation

            22.3.7.1. Overview

            22.3.7.2. Product Portfolio

            22.3.7.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.7.4. Sales Footprint

            22.3.7.5. Strategy Overview

                22.3.7.5.1. Marketing Strategy

                22.3.7.5.2. Product Strategy

                22.3.7.5.3. Channel Strategy

        22.3.8. Insulet Corporation

            22.3.8.1. Overview

            22.3.8.2. Product Portfolio

            22.3.8.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.8.4. Sales Footprint

            22.3.8.5. Strategy Overview

                22.3.8.5.1. Marketing Strategy

                22.3.8.5.2. Product Strategy

                22.3.8.5.3. Channel Strategy

        22.3.9. Ypsomed Holding AG

            22.3.9.1. Overview

            22.3.9.2. Product Portfolio

            22.3.9.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.9.4. Sales Footprint

            22.3.9.5. Strategy Overview

                22.3.9.5.1. Marketing Strategy

                22.3.9.5.2. Product Strategy

                22.3.9.5.3. Channel Strategy

        22.3.10. Sanofi

            22.3.10.1. Overview

            22.3.10.2. Product Portfolio

            22.3.10.3. Profitability by Market Segments (Product/Channel/Region)

            22.3.10.4. Sales Footprint

            22.3.10.5. Strategy Overview

                22.3.10.5.1. Marketing Strategy

                22.3.10.5.2. Product Strategy

                22.3.10.5.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Our Clients

Diabetes Diagnostics Market Forecast, Trend, Analysis & Competition Tracking - Global Market Insights 2020 to 2030